Sage Therapeutics: Showing Upside, But There Are Plenty Of Unknowns
With $2 billion in cash from a debatable Biogen deal, multiple data readouts in 2021, and insider buying after the recent readout-driven…
With $2 billion in cash from a debatable Biogen deal, multiple data readouts in 2021, and insider buying after the recent readout-driven…
A former Tesla Energy employee told Insider that a team of nine staff hunted for complaints specifically aimed at CEO Elon Musk….
A new spike in coronavirus cases, driven by the highly infectious Delta variant, rattled investors and companies last week.
These companies are benefiting from the economic recovery.
Markets are up big again so far this year, but don’t fear you’ve missed the boat.
Earnings season hits a higher gear over the next few trading days.
Jack Ma’s Ant has quietly run pilot tests using digital yuan; ‘it’s even more risky to stay on the sidelines,’ says one observer…
“It’s an astonishing success story and today we have nearly 1,000 active volunteers and only a small full-time staff”
Anyone can start a business, but it’s not guaranteed that it will succeed. One of the primary reasons a company fails is the…
Mazhar Mohammad of Chartviewindia.in said crossing the 15,900 level can give much-needed confidence to the bulls who can get…